Skip to main content
. Author manuscript; available in PMC: 2009 Sep 1.
Published in final edited form as: Cancer Res. 2008 Sep 1;68(17):6884–6888. doi: 10.1158/0008-5472.CAN-08-1101

Figure 4. BCR/ABL facilitates RAD52-ERCC1 co-localization.

Figure 4

(A) Western analysis of RAD52 and ERCC1 expression in parental and FTK-transformed cells cultured in the presence of IL-3. Actin served as loading control. (B) Detection of RAD52 (green), ERCC1 (red) and co-localizing (yellow) foci in parental and BCR/ABL-positive cells presented as percentage of RAD52 + ERCC1 staining/RAD52 staining. * p<10−5 in comparison to B/A. (C) Representative nuclear staining for RAD52 and ERCC1; white arrows indicate co-localization sites; nuclei borders are marked in blue.